Weaver Consulting Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Weaver Consulting Group's LLY Position: Q2 2026 in Review
Weaver Consulting Group increased its Eli Lilly (LLY) stake by 6.4% in Q2 2026, buying an estimated $33.7K and bringing the position to 551 shares worth $661K. The position accounts for 0.14% of the portfolio, ranked #132.
Weaver Consulting Group first reported a position in LLY in Q1 2019 and has held it in 26 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Weaver Consulting Group held 551 shares of Eli Lilly worth $661K as of Q2 2026.
- Weaver Consulting Group bought 33 Eli Lilly shares in Q2 2026, an estimated $33.7K.
- Eli Lilly made up 0.14% of Weaver Consulting Group's portfolio in Q2 2026, its #132 holding.
- Weaver Consulting Group first reported a position in Eli Lilly in Q1 2019 and has held it in 26 quarters since.
- 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Weaver Consulting Group's 13F filing for Q2 2026, filed 29 Jul 2026.